Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Sweeting

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Biometrical Journal. Biometrische Zeitschrift|April 25, 2017
Using predictions from a joint model for longitudinal and survival data to inform the optimal time of intervention in an abdominal aortic aneurysm screening programmeMichael J Sweeting
Pharmaceutical Statistics|March 14, 2012
Escalation strategies for combination therapy Phase I trialsMichael J Sweeting, Adrian P Mander
Statistics in Medicine|January 30, 2015
A product of independent beta probabilities dose escalation design for dual-agent phase I trialsAdrian P Mander, Michael J Sweeting
Biometrical Journal. Biometrische Zeitschrift|August 12, 2011
Joint modelling of longitudinal and time-to-event data with application to predicting abdominal aortic aneurysm growth and ruptureMichael J Sweeting, Simon G Thompson
Plos One|July 13, 2016
AplusB: A Web Application for Investigating A + B Designs for Phase I Cancer Clinical TrialsGraham M Wheeler, Michael J Sweeting, Adrian P Mander
Statistics in Medicine|December 2, 2005
Bayesian back-calculation using a multi-state model with application to HIVMichael J Sweeting, Daniela De Angelis, Odd O Aalen
Statistics in Medicine|April 30, 2004
What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse dataMichael J Sweeting, Alexander J Sutton, Paul C Lambert
Statistics in Medicine|March 16, 2017
Toxicity-dependent feasibility bounds for the escalation with overdose control approach in phase I cancer trialsGraham M Wheeler, Michael J Sweeting, Adrian P Mander
Biometrical Journal. Biometrische Zeitschrift|September 4, 2018
Biases incurred from nonrandom repeat testing of haemoglobin levels in blood donors: Selective testing and its implicationsRyan K Chung, Angela M Wood, Michael J Sweeting
Journal of the Royal Statistical Society. Series C, Applied Statistics|March 19, 2019
A Bayesian model-free approach to combination therapy phase I trials using censored time-to-toxicity dataGraham M Wheeler, Michael J Sweeting, Adrian P Mander
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Biometrical Journal. Biometrische Zeitschrift|April 25, 2017
Using predictions from a joint model for longitudinal and survival data to inform the optimal time of intervention in an abdominal aortic aneurysm screening programmeMichael J Sweeting
Pharmaceutical Statistics|March 14, 2012
Escalation strategies for combination therapy Phase I trialsMichael J Sweeting, Adrian P Mander
Statistics in Medicine|January 30, 2015
A product of independent beta probabilities dose escalation design for dual-agent phase I trialsAdrian P Mander, Michael J Sweeting
Biometrical Journal. Biometrische Zeitschrift|August 12, 2011
Joint modelling of longitudinal and time-to-event data with application to predicting abdominal aortic aneurysm growth and ruptureMichael J Sweeting, Simon G Thompson
Plos One|July 13, 2016
AplusB: A Web Application for Investigating A + B Designs for Phase I Cancer Clinical TrialsGraham M Wheeler, Michael J Sweeting, Adrian P Mander
Statistics in Medicine|December 2, 2005
Bayesian back-calculation using a multi-state model with application to HIVMichael J Sweeting, Daniela De Angelis, Odd O Aalen
Statistics in Medicine|April 30, 2004
What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse dataMichael J Sweeting, Alexander J Sutton, Paul C Lambert
Statistics in Medicine|March 16, 2017
Toxicity-dependent feasibility bounds for the escalation with overdose control approach in phase I cancer trialsGraham M Wheeler, Michael J Sweeting, Adrian P Mander
Biometrical Journal. Biometrische Zeitschrift|September 4, 2018
Biases incurred from nonrandom repeat testing of haemoglobin levels in blood donors: Selective testing and its implicationsRyan K Chung, Angela M Wood, Michael J Sweeting
Journal of the Royal Statistical Society. Series C, Applied Statistics|March 19, 2019
A Bayesian model-free approach to combination therapy phase I trials using censored time-to-toxicity dataGraham M Wheeler, Michael J Sweeting, Adrian P Mander
Pageof 8